Effect of exendin (exenatide) - GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model

European Journal of Pharmacology

Volumn 691, Issue 1-3, 2012, Pages 292-296

  Bulchandani, Deepti ^a   Nachnani, Jagdish S ^a   Herndon, Betty ^b   Molteni, Agostino ^b   Pathan, Muhammad H ^b   Quinn, Tim ^b   Hamdan, Hana A ^b   Alba, Laura M ^b,c   Graves, Leland ^d  

^a Summer Medical Group   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c Saint Luke's Hospital of Kansas City   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Exendin 4; GLP 1; Parathyroid; Rat; Thyroid

Indexed keywords

CALCITONIN; CALCIUM; CARCINOEMBRYONIC ANTIGEN; EXENDIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CELL COUNT; CELL DAMAGE; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFECT; HISTOPATHOLOGY; MALE; MULTICENTER STUDY; NONHUMAN; PARATHYROID CELL; PARATHYROID GLAND; PRIORITY JOURNAL; RAT; SECRETORY GRANULE; THYROID PARAFOLLICULAR CELL;

ANIMALS; CALCITONIN; CALCIUM; CARCINOEMBRYONIC ANTIGEN; MALE; PARATHYROID GLANDS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; THYROID GLAND; VENOMS;

EID: 84865020296     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.07.024     Document Type: Article

References (20)

1. E.J. Abraham, C.A. Leech, J.C. Lin, H. Zulewski, and J.F. Habener Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells Endocrinology 143 2002 3152 3161 (Pubitemid 34809888)
2. S.R. Ahmad, and J. Swann Exenatide and rare adverse events N Engl. J. Med. 358 2008 1970 1971 discussion 1971-1972 (Pubitemid 351620133)
3. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157 (Pubitemid 46711096)
4. K. Ban, K.H. Kim, C.K. Cho, M. Suave, E.P. Diamandis, P.H. Backx, D.J. Drucker, and M. Husain Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor Endocrinology 151 2010 1520 1531
5. K. Ban, M.H. Noyan-Ashraf, J. Hoefer, S.S. Bolz, D.J. Drucker, and M. Husain Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways Circulation 117 2008 2340 2350 (Pubitemid 351653542)
6. L. Bjerre Knudsen, L.W. Madsen, S. Andersen, K. Almholt, A.S. de Boer, D.J. Drucker, C. Gotfredsen, F.L. Egerod, A.C. Hegelund, H. Jacobsen, S.D. Jacobsen, A.C. Moses, A.M. Molck, H.S. Nielsen, J. Nowak, H. Solberg, T.D. Thi, and M. Zdravkovic Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation Endocrinology 151 2010 1473 1486
7. P.L. Brubaker Minireview: update on incretin biology: focus on glucagon-like peptide-1 Endocrinology 151 2010 1984 1989
8. D.D. De Leon, M.F. Crutchlow, J.Y. Ham, and D.A. Stoffers Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus Int. J. Biochem. Cell Biol. 38 2006 845 859 (Pubitemid 43363416)
9. P.S. Denker, and P.E. Dimarco Exenatide (exendin-4)-induced pancreatitis: a case report Diabetes Care 29 2006 471 (Pubitemid 44106551)
10. R. Goke, H.C. Fehmann, T. Linn, H. Schmidt, M. Krause, J. Eng, and B. Göke Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells J. Biol. Chem. 268 1993 19650 19655 (Pubitemid 23270754)
11. M. Korner, M. Stockli, B. Waser, and J.C. Reubi GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting J. Nucl. Med. 48 2007 736 743 (Pubitemid 47604973)
12. Y. Lamari, C. Boissard, M.S. Moukhtar, A. Jullienne, G. Rosselin, and J.M. Garel Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1 FEBS Lett. 393 1996 248 252 (Pubitemid 26298105)
13. Liraglutide (Package insert Accessed from Drug facts and comparisons on line, 2008 〈http://www.victoza.com/pdf/Victoza-ComboPI-5.24.pdf〉 (accessed 30.12.10).
14. K.E. Mayo, L.J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D.J. Drucker International Union of Pharmacology. XXXV. The glucagon receptor family Pharmacol. Rev. 55 2003 167 194 (Pubitemid 36268402)
15. J.S. Nachnani, D.G. Bulchandani, A. Nookala, B. Herndon, A. Molteni, P. Pandya, R. Taylor, T. Quinn, L. Weide, and L.M. Alba Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas Diabetologia 53 2010 153 159
16. M.A. Nauck, N. Kleine, C. Orskov, J.J. Holst, B. Willms, and W. Creutzfeldt Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients Diabetologia 36 1993 741 744 (Pubitemid 23218642)
17. Parola, A., 2009. FDA Advisory Committee Non-Clinical Briefing Document. Pharmacology/Toxicology Review of Thyroid C-cell Tumors in Rats and Mice, in: Dept. DHHS, PHS, Food and Drug Administration, Center for Drug Evaluation and Research, 〈http://www.fda.gov/ohrms/dockets/ac/cder08. html#EndocrinologicMetabolic〉, pp. 14-18.
18. H.W. Rodbard, L. Blonde, S.S. Braithwaite, E.M. Brett, R.H. Cobin, Y. Handelsman, R. Hellman, P.S. Jellinger, L.G. Jovanovic, P. Levy, J.I. Mechanick, and F. Zangeneh American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus Endocr. Pract. 13 Suppl 1 2007 1 68
19. G.G. Sokos, L.A. Nikolaidis, S. Mankad, D. Elahi, and R.P. Shannon Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure J. Card. Fail. 12 2006 694 699 (Pubitemid 44881367)
20. W.F. Ward, Y.T. Kim, A. Molteni, and N.H. Solliday Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme Int. J. Radiat. Oncol. 15 1988 135 140